VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Haisco's Innovative Non-Opioid Analgesic HSK51155 Tablet Receives NMPA Clinical Trial Acceptance; Global Exclusive License with AbbVie Previously Secured
Haisco's Innovative Non-Opioid Analgesic HSK51155 Tablet Receives NMPA Clinical Trial Acceptance; Global Exclusive License with AbbVie Previously Secured
Jun 09, 2026 16:21 CST Updated 17:07
Share:
Haisco
New Drug Research and Development, Production, and Sales